Treatment of hereditary spinal cerebellar ataxia with Stem cell transplantation

Stem cell transplantation for treatment of spinocerebellar ataxia type 3

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047705

Enrollment

Unknown

Registered

2021-06-23

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditary spinocerebellar ataxias

Interventions

Experimental group:Stem Cell Therapy

Control group:Conventional treatment

Eligibility

Sex/Gender

All

Age

6 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Aged 6 to 18 years; 2. With or without family history of ataxia; 3. Genetic testing is ATXN3 dynamic mutation.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

Measure	Time frame
Ataxia Rating Scale;	—

Countries

China

Contacts

Public ContactWang Sanmei

The Seventh Medical Center, PLA General Hospital

wangsanmei66@163.com+86 13683383295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026